A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: A Gynecologic Oncology Group study

Cancer Causes and Control

Volumn 23, Issue 12, 2012, Pages 2013-2021

  Carter, Randy L ^a,b   Kang, Le ^b   Darcy, Kathleen M ^a,f   Kauderer, James ^a   Liao, Shu Yuan ^c   Rodgers, William H ^d   Walker, Joan L ^e   Lankes, Heather A ^a   Dunn, S Terence ^e   Stanbridge, Eric J ^c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LENOX HILL HOSPITAL   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f The Henry M Jackson Foundation for the Advancement of Military Medicine Department of Defense   (United States)

Author keywords

Atypical glandular cells; Carbonic anhydrase IX; GOG; HPV; Human papillomavirus

Indexed keywords

CARBONATE DEHYDRATASE IX;

ACCURACY; ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; ATYPICAL GLANDULAR CELL OF UNDETERMINED SIGNIFICANCE; CLINICAL ASSESSMENT; FEMALE; FOLLOW UP; GENOTYPE; GYNECOLOGIC DISEASE; HIGH RISK POPULATION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MODIFIED LATENT CLASS MODEL ANALYSIS; OBSERVATIONAL STUDY; PAPANICOLAOU TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SIGNIFICANT CERVICAL LESION; STATISTICAL ANALYSIS; UNITED STATES; UTERINE CERVIX DISEASE; WART VIRUS; WOMEN'S HEALTH;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; VAGINAL SMEARS; YOUNG ADULT;

EID: 84878829573     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0081-0     Document Type: Article

References (31)

1. Kennedy AW, Salmieri SS, Wirth SL, Biscotti CV, Tuason LJ, Travarca MJ (1996) Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol 3:14-18
2. Wilbur DC (1995) Endocervical glandular atypia: a "new" problem for the cytologist. Diagn Cytopathol 13:463-469
3. Lee KR, Manna EA, St John T (1995) Atypical endocervical glandular cells: accuracy of cytologic diagnosis. Diagn Cytopathol 13:202-208
4. Nasu I, Meurer W, Fu YS (1993) Endocervical glandular atypia and adenocarcinoma: a correlation of cytology and histology. Int J Gynecol Pathol 12:208-211
5. Liao SY, Rodgers WH, Kauderer J et al (2009) Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States. Int J Cancer 125:2434-2440
6. Schnatz PF, Guile M, O'Sullivan DM, Sorosky JL (2006) Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol 107:701-708
7. Sieber AG, Massuger LFAG, Bulten J (2007) Referral compliance, outcome and predictors of CIN after repeated borderline cervical smears in the Netherlands. Cytopathology 18:96-104
8. Valenstein P (1990) Evaluating diagnostic tests with imperfect standards. Am J Clin Pathol 93:252-258
9. Gaffikin L, McGrath JA, Arbyn M, Blumenthal PD (2007) Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis. BMC Med Res Methodol 7:36
10. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB (2000) Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 156:1158-1171
11. Liao SY, Brewer C, Závada J et al (1994) Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinoma. Am J Pathol 145:598-609
12. Liao SY, Stanbridge EJ (1994) Expression of the MN antigen in cervical Papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 5:549-557
13. Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE (2008) A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiol Biomarkers Prev 17:1248-1254
14. Castle PE, Sadorra M, Garcia F, Holladay EB, Kornegay J (2008) Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology. J Clin Microbiol 44:3915-3917
15. Lazarsfeld P, Henry N (1968) Latent structure analysis. Houghton Mifflin Co., Boston
16. Walter SD, Irwig LM (1988) Estimation of error rates, disease prevalence and relative risk from misclassified data: a review. J Clin Epidemiol 41:923-938
17. Uebersax JS, Grove WM (1990) Latent class analysis of diagnostic agreement. Stat Med 9:559-572
18. Dempster AP, Laird NM, Rubin DB (1977) Maximum likelihood estimation from incomplete data via the EM algorithm. J Royal Stat Soc Ser B 39:1-38
19. Wei GCG, Tanner MA (1990) A Monte Carlo implementation of the EM algorithm and the poor man's data augmentation algorithms. J Am Stat Assoc 85:699-704
20. Bland M (2000) An introduction to medical statistics, 3rd edn. Oxford University Press, Oxford
21. Efron B, Tibshirani RJ (1993) An introduction to the bootstrap. Chapman and Hall/CRC, Boca Raton
22. Pretorius RG, Bao YP, Belinson JL, Burchette RJ, Smith JS, Qiao YL (2007) Inappropriate gold standard bias in cervical cancer screening studies. Int J Cancer 121(10):2218-2224
23. Poljak M, Marin IJ, Seme K, Vince A (2002) Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high risk cocktail. J Clin Virol 25(Suppl. 3):S89-S97
24. Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M (2008) Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol 46:109-117
25. Castle PE, Schiffman M, Burk RD et al (2002) Restricted cross-reactivity of hybrid capture 2 with non-oncogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 11:1394-1399
26. Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M (2008) Human papillomavirus genotype specificity of Hybrid Capture 2. J Clin Microbiol 46:2595-2604
27. Liao SY, Rodgers WH, Kauderer J et al (2010) Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study. Br J Cancer 104:353-360
28. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papilloma virus and cervical cancer. Lancet 370:890-907
29. Kinney W, Stoler MH, Castle PE (2010) Patient safety and the next generation of HPV DNA tests. Am J Clin Pathol 134:193-199
30. Castle PE, Katki HA (2010) Benefits and risks of HPV testing in cervical cancer screening. Lancet Oncol 11:214-215
31. Arbyn M, Kyrgiou M, Simoens C et al (2008) Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 337:a1284